AI-Driven Formulation Design

The project centers on using AI to design drug formulations, a process that traditionally relies on extensive laboratory experimentation to determine how active ingredients are combined with excipients into final dosage forms. By entrusting formulation design to AI-based methods, the project aims to accelerate development workflows that have historically been time- and resource-intensive.

As the lead institution of the national project, Daewoong Pharmaceutical will oversee the research effort. The designation places the company in charge of coordinating the project's goals and execution under the government-funded framework.

Significance for Korea's AI-Pharma Push

The selection underscores the growing role of AI in Korean pharmaceutical research, where formulation design is among the stages that stand to benefit from machine-learning approaches. National research projects of this kind typically pair a lead company with partner institutions and are funded as part of state support for advanced technology development.

Daewoong Pharmaceutical, one of South Korea's established drugmakers, has been expanding its research capabilities, and the new mandate formalizes its move into AI-assisted formulation work at the national project level.

The claim that Daewoong Pharmaceutical was selected as the lead institution of a national project applying AI to drug formulation design is True.